Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China	Bone Diseases, Metabolic, Nutritional and Metabolic Diseases, bone disorder, metabolic disease, musculoskeletal system disorder, osteoporosis	Active, not recruiting	Phase 4	2026-02-12		NCT06332014

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Amgen	180

16 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beijing Jishuitan Hospital	Beijing	China	9
Huaian First Peoples Hospital	Huaian	China	2
Jiangxi Provincial Peoples Hospital	Nanchang	China	1
Nanfang Hospital Southern Medical University	Guangzhou	China	8
Peking University First Hospital	Beijing	China	163
Pingxiang Peoples Hospital	Pingxiang	China	2
Qilu Hospital of Shandong University	Jinan	China	138
Shanghai Sixth Peoples Hospital	Shanghai	China	2
Sun Yat-sen Memorial Hospital Sun Yat-sen University	Guangzhou	China	3
The Affiliated Hospital of Xuzhou Medical University	Xuzhou	China	15
The First Affiliated Hospital of Chongqing Medical University	Chongqing	China	7
The First Affiliated Hospital of Soochow University	Suzhou	China	101
The First Peoples Hospital of Kunshan	Suzhou	China	2
The Fourth Hospital of Harbin Medical University	Harbin	China	5
The Second Affiliated Hospital of Nanjing Medical University	Nanjing	China	16
Xuzhou Central Hospital	Xuzhou	China	20